Bone Biologics (NASDAQ:BBLG) reported quarterly losses of $(0.17) per share. This is a 21.43 percent decrease over losses of $(0.14) per share from the same period last year.
UPDATE: Amryt Pharma Q4 EPS $(0.07) Beats $(0.15) Estimate, Sales $54.83M Miss $56.81M Estimate
Amryt Pharma (NASDAQ:AMYT) reported quarterly losses of $(0.07) per share which beat the analyst consensus estimate of $(0.15) by 53.33 percent. This is a 75 percent increase over losses of $(0.28) per share from the
